Found 13 matching trials
An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/Ml NA To provide product through an expanded access program to HIV-infected patie...
Show More Location
Immune Response Corp
Learn More & Join Trial
An Expanded Access Open Label Protocol of Remune (HIV-1 Immunogen) in HIV-1-Infected Adults With CD4 Count 550 Cells /Ml and Greater. NA To provide an alternative therapy to HIV-infected patients for whom there i...
Show More Location
Immune Response Corp
Learn More & Join Trial
Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune) PHASE3 The purpose of this study is to see if it is effective to add an HIV vaccin...
Show More Location
Agouron Pharmaceuticals Inc
Learn More & Join Trial
REMUNE + AMPLIVAX IR103 HIV/AIDS Phase III Safety & Efficacy Study PHASE3 The primary objective is to compare \& evaluate between the treatment group...
Show More Location
Clinical Site TBA
Learn More & Join Trial
A Study to Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328 NA The purpose of this study is to determine the effects of an HIV vaccine (Re...
Show More Location
Univ. of Iowa Healthcare, Div. of Infectious Diseases
Learn More & Join Trial
REMUNE HIV/AIDS Vaccine Phase II Pediatric Safety & Efficacy Clinical Study PHASE2 The primary objective is to compare \& evaluate between the treatment group...
Show More Location
Clinical Site TBA
Learn More & Join Trial
Evaluating the Combined Intervention of Nutritional Supplementation (Remune) and Exercise in Patients With Cancer Cachexia PHASE1 The main purpose of this research study is to determine if the use of a nut...
Show More Location
University of Rochester
Learn More & Join Trial
Effectiveness of Giving an HIV Vaccine (Remune) to HIV-Positive Patients Receiving an Anti-HIV Drug Combination PHASE3 The purpose of this study is to look at the effects of the HIV vaccine Remu...
Show More Learn More & Join Trial
Safety and Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune) PHASE2 The purpose of this study is to see if giving HIV-positive patients an HIV ...
Show More Location
Agouron Pharmaceuticals Inc
Learn More & Join Trial
A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega PHASE3 To determine the effect of HIV-1 immunogen (Remune) on AIDS-free survival, ...
Show More Location
Phoenix Body Positive
Learn More & Join Trial